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Background: Percutaneous pulmonary interventions require extensive and accurate navigation planning 
and guidance, especially in regard to the three-dimensional (3D) relationships between anatomical structures. 
In this study, we are demonstrating the feasibility of novel visualization techniques: 3D printing (3DP) and 
augmented reality (AR) in planning transcatheter pulmonary interventions.
Methods: Two patients were qualified for balloon pulmonary angioplasty (BPA) for treatment of chronic 
thromboembolic pulmonary hypertension (CTEPH) and stent implantation for pulmonary artery stenosis, 
respectively. Computed tomography images of both patients were processed with segmentation algorithms 
and subsequently submitted to 3D modelling software. Microsoft HoloLens® AR headsets with dedicated 
CarnaLife Holo® software were utilized to display surface and volume rendering of pulmonary vessels as 
holograms. 
Results: Personalized life-sized models of the same structures were additionally 3D-printed for 
preoperative planning. Holograms were shown to physicians throughout the procedure and were used as a 
guidance and navigation tool. Operative team was able to manipulate the hologram and multiple users of the 
AR system could share the same image in real time. Clinicians expressed their satisfaction with the quality of 
imaging and potential clinical benefits. 
Conclusions: This study reports the potential value of AR in pulmonary interventions, however, 
prospective trials need to be conducted to decide on whether novel 3D visualization techniques affect 
perioperative treatment and outcomes.
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Introduction
Percutaneous cardiovascular interventions on pulmonary 
arteries are still associated with major technical challenges 
and require extensive planning and intraprocedural precise 
visualization methods. Pulmonary vascular tree is characterized 
with complex, three-dimensional (3D) anatomy that is difficult 
to visualize precisely with planar angiography. Chronic 
thromboembolic pulmonary hypertension (CTEPH) is related 
to presence of multiple post-thrombotic lesions disseminated 
in different branches of pulmonary arteries. Promising results 
of balloon pulmonary angioplasty (BPA) were reported in 
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treatment of persistent or recurrent CTEPH (1,2). One of 
the most important requirements for effective treatment 
of CTEPH with BPA is an accomplishment of effective 
dilatations in the largest possible number of segmental and 
subsegmental pulmonary arteries (3). Ogo et al. reported 
successful use of cone beam computed tomography in 
supporting BPA procedures with 3D image reconstructions (4). 
However, currently available tools have limited availability and 
there is still a need for novel techniques that would represent 
patient’s anatomy especially accurately in regards to 3D 
relationships between structures.
In recent years, several new approaches emerged to 
provide 3D visualization of medical data, including 3D 
printing (3DP), augmented reality (AR) or virtual reality 
(VR). 3DP and AR are considered especially useful since 
they can guide physicians during the procedures. However, 
literature is very limited and consists of only few pilot and 
feasibility studies. AR systems have been researched in many 
disciplines including urology (5), neurosurgery (6), while in 
cardiology AR was found feasible i.e., in revascularization of 
coronary chronic total occlusion (7) and transcatheter aortic 
valve implantation (8,9). 3DP is much more explored with a 
wide range of applications in cardiology field (10), including 
preclinical studies of printing pulmonary artery models (11). 
Having said that, no feasibility studies evaluating use of 
neither 3DP nor AR were performed in clinical setting with 
patients undergoing transcatheter pulmonary interventions. 
Thus, the aim of this study was to evaluate the usefulness 
of 3D printing and AR system in planning and guidance of 




A 53-year-old male with persistent CTEPH despite 
previous treatment with pulmonary endarterectomy, 
chronic kidney disease in stage 3a, chronic obstructive 
pulmonary disease, hypothyroidism, and splenectomy 
performed years ago was referred for BPA. He was 
administered specific medical therapy with riociguat at 
the dose 2.5 mg three times a day (TID). He presented 
symptoms of NYHA functional class III on admission. 
N-terminal prohormone of brain natriuretic peptide (NT-
proBNP) plasma level concentration was increased to 
818 pg/mL. In the 6 minutes walk test (6MWT) he covered 
the distance of 318 m with severe dyspnea (5 points in 
Borg index) and desaturation from 93–90% (no oxygen 
supplementation). Right heart catheterization (RHC) 
performed in accordance to current standards (12) after 
pulmonary endarterectomy confirmed severe pulmonary 
hypertension (mPAP: 46 mmHg) with normal cardiac index 
(CI: 3.08 L/min/m2), normal capillary pulmonary wedge 
pressure (PCWP: 9 mmHg) and increased pulmonary 
vascular resistance (PVR: 6.42 Wood units). The patient 
suffered from chronic kidney disease and his glomerular 
filtration rate (GFR) was decreased to 42 mL/min/1.73 m2. 
Angiography of both pulmonary arteries revealed residual 
clots in segmental and subsegmental branches. 
The first BPA session was performed on eight segmental 
and subsegmental arteries in the right lobe. There were no 
complications during and after first procedure. According 
to poor renal function, the reduction of contrast medium 
was planned in the 2nd session. 3D-printed model of the 
patient’s left pulmonary artery was developed in order to 
better understand the anatomy of the lesions and check the 
feasibility of the procedure. During the second BPA session, 
an AR system was used as an additional tool. After the series 
of 6 BPA procedures, patient’s functional capacity improved 
to NYHA II class. Controlled RHC presented reduction 
of mPAP to 38 mmHg and PVR 4.38 Wood units. The 
improvement of renal function (eGFR >60 mL/min/1.73 m2) 
and decrease of NT-proBNP to 324 pg/mL was noted.
Case 2
A 67-year-old male with pulmonary precapi l lary 
hypertension associated with idiopathic mediastinal fibrosis 
and proximal ring-like stenosis of pulmonary arteries 
resulting from abnormal connective tissue consolidation 
in mediastinum, with coronary artery disease, paroxysmal 
atrial fibrillation was admitted for interventional treatment. 
The patient was administered specific medical therapy with 
sildenafil without any significant clinical and hemodynamical 
improvement. He presented symptoms of NYHA functional 
class III on admission and reported deterioration in health 
related quality of life. The NT-proBNP plasma level 
concentration was normal. He covered the distance of 363 
m in 6MWT with very severe dyspnea (8 points in Borg 
index) and without any significant desaturation (from 98% 
to 97%). RHC performed at rest confirmed mPAP increase 
to 29 mmHg, decreased CI to 2.38 L/min/m2, normal 
PCWP 14 mmHg and borderline PVR 3.01 Wood units. 
During the catheterization, a gradient of systolic PAP (from 
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53 to 38 mmHg) was noticed when crossing the ring-like 
stenosis in pulmonary lobar artery by Swan-Ganz catheter.
During the first session, a selective angiography 
confirmed proximal stenosis of left artery of lower lobe. An 
assessment with pressure wire (Verrata, Philips Volcano) 
confirmed significant gradient across the narrowed 
artery (Pdist: 19 mmHg; Pprox: 28 mmHg; Pdist/Pprox: 0.67). 
Intravascular ultrasound (IVUS) showed significant 
reduction (over 50%, area of 23 mm2) of the lumen of 
pulmonary artery of left lower lobe. Self-expanding stent 
CID (CID S.p.A, Alvimedica Group, Istanbul, Turkey) 
12/40 mm was implanted in the occluded vessel. After 
implantation, a significant improvement in functional 
pressure assessment (Pdist: 29 mmHg, Pprox: 30 mmHg; Pdist/
Pprox: 0,96) and increase in the area of the vessel to 72 mm
2 
were confirmed in IVUS.
The second session was performed in the right lower lobe 
artery, where significant ring-like stenosis was confirmed 
in 3D rotational pulmonary angiography. AR visualization 
was used for navigation of stenotic lesion and crossing it 
by guidewire. Pressure wire confirmed significant gradient 
across the lesion (Pdist: 19 mmHg, Pprox: 28 mmHg; Pdist/Pprox: 
0.67) and IVUS showed the >50% reduction in proximal 
right lower lobe pulmonary artery. Self-expanding stent 
EPIC 12/40 mm (Boston Scientific, Marlborough, MA, 
USA) was implanted and post-dilatation of Advance 35LP 
12/18 mm (Cook Medical, Bloomington, IN, USA) balloon 
was performed. There were no complications during 
procedure and improvement of pressure gradient (Pdist: 
25 mmHg, Pproxd 26 mmHg; Pdist/Pprox: 0.96) was confirmed. 
Control RHC performed after 2 invasive procedures 
with stent implantation confirmed decrease of mPAP to 
25 mmHg.
Image acquisition and processing
All images were registered with Philips Brilliance Big Bore 
CT (Koninklijke Philips Electronics NV, Eindhoven, 
Netherlands) scanner with 120 kVp protocol and 1.00 mm 
slice thickness. Studies saved in Digital Imaging and 
Communications in Medicine (DICOM) format were 
imported into 3D Slicer (version 4.8.1) for further 
processing (13). Built-in semi-automatic algorithms 
were used for initial segmentation which results were 
subsequently manually refined and exported into 3D 
meshes. In Blender 3D modelling software (open-source; 
Blender Foundation, Amsterdam, Netherlands) pulmonary 
arteries were divided into parts including segmental and 
subsegmental branches feeding upper lobe, lingula/middle 
lobe and lower lobe, respectively (Figure 1).
Results
3D printing and AR
3D objects require preparation specifically for 3D printing, 
including making meshes watertight and ensuring that 
multipart printouts will fit each other. To achieve that, we 
used Boolean-based approach described elsewhere (14). 
Ultimaker 2+ (Ultimaker, Geldermalsen, Netherlands) 3D 
printer with polylactic acid (PLA) material and Form 2 
(Formlabs, Somerville, MA, USA) with transparent resin, 
were used for printing all parts which were assembled 
together later (Figure 2).
3DP models were developed and delivered to the 
surgical team prior to the procedure. Clinicians reported 
that there was no difference in terms of quality or utility of 
3DP models depending on used material and fabrication 
method. Also, AR system was provided a few hours before 
planned operations. Developers of the AR system were on 
site dedicated to assisting physicians in case of any issues 
and they conducted a short introduction before going into 
the surgical room.
CarnaLife Holo® (MedApp, Kraków, Poland) software 
was used to visualize pulmonary arteries in holographic 
form, utilizing both volume and surface rendering (Figure 3). 
Operative team was able to manipulate the hologram 
(moving, zooming, rotating, cutting, changing transfer 
functions) with gestures and voice commands. Team 
performing the intervention had the AR headset on 
throughout the procedure and was able to refer to the 
hologram at any time. As reported, the hardware nor the 
method of visualization did not obstruct the vision. As 
for hardware, three Microsoft HoloLens® head-mounted 
displays were used. The AR system enables users to visualize 
medical datasets loaded directly from DICOM files or 
connected PACS system and utilized software implements 
the ability to share the same hologram between multiple 
users, so that all members of the operative team could 
discuss the image at the same time (Figure 4) (Online video: 
https://www.youtube.com/watch?v=CxYsZGB-CCw).
Discussion
We have conducted a feasibility study of 3D printing 
and AR for pulmonary interventions in a clinical setting 
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Figure 1 Image processing for surface rendering. (A) Raw CT scan; (B) CT with segmentation overlay mask (pink); (C) exported 




Figure 2 3DP models fabricated with white polylactic acid (A), flexible resin (B) and multi-part polylactic acid model (C). 3DP, three-
dimensional printing.
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Figure 3 First person view of holograms displayed throughout the procedures. (A) surface rendering of pulmonary artery with selected 
branches highlighted in a different color (blue, red, green); (B) volume-rendering-based hologram of pulmonary artery and its branches.
A B
Figure 4 Operative team during one of the procedures. The AR 
software used in these cases enables multiple users to share the 
same image in real time. AR, augmented reality.
with two real patient cases. 3D models in physical and 
holographic form were used during the process of 
preparing for surgery, and while performing the procedure. 
3D-printed pulmonary artery was used primarily as a 
preoperative planning tool, while AR system primary use 
was for navigation and guidance. However, both were 
available for the whole process.
Head-mounted AR displays have been found to be safe 
and clinically useful in percutaneous procedures. Opolski 
et al. revealed that patients in group treated with AR 
assistance had lower contract exposure with no risks to 
procedural safety (7). Clinical cases published recently by 
Lodziński et al. (15) and Rymuza et al. (8) confirm accuracy 
of holograms for cardiovascular interventions. Regarding 
3DP, there is strong evidence supporting its use in planning 
difficult transcatheter interventions. However, only a few 
describe specifically pulmonary procedures. El Sabbagh 
et al. showed that 3DP model was useful in preprocedural 
assessment of location of pulmonary obstruction and stent 
sizing (10). This is the first report of AR application in 
interventional treatment of non-congenital pulmonary 
artery branches stenosis caused by fibrotic lesions or 
thrombotic material. Potential role of AR and 3DP in 
improvement of BPA technique is related to better selection 
of target lesions, providing more complete revascularization, 
avoiding vessel injury caused by oversized balloons and 
decreasing the volume of contrast medium. In procedures 
requiring stent implantation, augmented 3D visualization is 
crucial in stent sizing and positioning to avoid unnecessary 
closure of side branches which are prominently developed 
in pulmonary circulation. 
Our study has some limitations that have to be taken into 
consideration. Primarily, this is a feasibility study that can 
be treated as a proof of concept. Although opinions of all 
physicians engaged in the process were positive about its 
accuracy, usability and potential effectiveness in routine use, 
it is yet to be decided how the use of these technologies will 
affect perioperative parameters and outcomes. Prospective 
trials in the future will decide if novel 3D visualizations 
techniques are cost-effective.
There is also a debate when and where we should use 
3DP instead of AR. In our study, operators had access to 
both technologies at all times and they felt it was more 
natural to use 3D printed models prior to the surgery for 
additional tactile experience and more straightforward 
manipulation, while during the procedure they almost 
exclusively used AR which allowed them to visualize 
structures with gestures and voice commands.
Thinking about  further  development  of  these 
visualization techniques, it seems that AR might offer more 
powerful toolset in several years if progress in hardware and 
other areas like artificial intelligence, advances simulations 
28 Witowski et al. AR in pulmonary interventions
© Quantitative Imaging in Medicine and Surgery. All rights reserved.   Quant Imaging Med Surg 2019;9(1):23-29qims.amegroups.com
continues. When AR surpasses the point of being able 
to mimic tissues mechanical properties—which is major 
limitation of 3D printing—it will become able to simulate 
not only physical mechanisms like fluid simulation, but also 
perform whole mock procedures. Until then, 3DP seems a 
great addition when planning and measuring preoperatively, 
and is even more encouraging when used for education. 
Conclusions
This technical note suggests that in cases with changed and 
difficult anatomy of pulmonary arteries, imaging with CT 
aided by 3D printed model and AR is helpful. The strategy 
with novel 3D visualization techniques has potential to 
reduce the dosage of contrast medium and minimize the 




Conflicts of Interest: J Witowski and J Kamiński are employed 
by MedApp S.A., Marcin Kurzyna and Łukasz Kownacki 
are members of MedApp S.A. scientific advisory board.
Ethical Statement: All procedures performed in studies 
involving human participants were in accordance with 
the ethical standards of the institutional and/or national 
research committee and with the 1964 Helsinki Declaration 
and its later amendments or comparable ethical standards. 
Informed consent was obtained from all individual 
participants included in the study. 
References
1. Darocha S, Pietura R, Pietrasik A, Norwa J, Dobosiewicz A, 
Piłka M, Florczyk M, Biederman A, Torbicki A, Kurzyna 
M. Improvement in Quality of Life and Hemodynamics 
in Chronic Thromboembolic Pulmonary Hypertension 
Treated With Balloon Pulmonary Angioplasty. Circ J 
2017;81:552-7. 
2.  Kurzyna M, Darocha S, Pietura R, Pietrasik A, Norwa 
J, Mańczak R, Wieteska M, Biederman A, Matsubara H, 
Torbicki A. Changing the strategy of balloon pulmonary 
angioplasty resulted in a reduced complication rate 
in patients with chronic thromboembolic pulmonary 
hypertension. A single-centre European experience. 
Kardiol Pol 2017;75:645-54. 
3.  Kurzyna M, Darocha S, Koteja A, Pietura R, Torbicki 
A. Balloon pulmonary angioplasty for chronic 
thromboembolic pulmonary hypertension. Postepy 
Kardiol Interwencyjnej 2015;11:1-4. 
4.  Ogo T, Fukuda T, Tsuji A, Fukui S, Ueda J, Sanda Y, 
Morita Y, Asano R, Konagai N, Yasuda S. Efficacy and 
safety of balloon pulmonary angioplasty for chronic 
thromboembolic pulmonary hypertension guided by cone-
beam computed tomography and electrocardiogram-
gated area detector computed tomography. Eur J Radiol 
2017;89:270-6. 
5.  Wake N, Bjurlin MA, Rostami P, Chandarana H, Huang 
WC. Three-dimensional Printing and Augmented 
Reality: Enhanced Precision for Robotic Assisted Partial 
Nephrectomy. Urology 2018;116:227-8. 
6.  Guha D, Alotaibi NM, Nguyen N, Gupta S, McFaul 
C, Yang VXD. Augmented Reality in Neurosurgery: A 
Review of Current Concepts and Emerging Applications. 
Can J Neurol Sci 2017;44:235-45. 
7.  Opolski MP, Debski A, Borucki BA, Staruch AD, Kepka 
C, Rokicki JK, Sieradzki B, Witkowski A. Feasibility 
and safety of augmented-reality glass for computed 
tomography-assisted percutaneous revascularization 
of coronary chronic total occlusion: A single center 
prospective pilot study. J Cardiovasc Comput Tomogr 
2017;11:489-96. 
8.  Rymuza B, Grodecki K, Kamiński J, Scisło P, Huczek Z. 
Holographic imaging during transcatheter aortic valve 
implantation procedure in bicuspid aortic valve stenosis. 
Kardiol Pol 2017;75:1056. 
9.  Currie ME, McLeod AJ, Moore JT, Chu MW, Patel R, Kiaii 
B, Peters TM. Augmented Reality System for Ultrasound 
Guidance of Transcatheter Aortic Valve Implantation. 
Innovations (Phila) 2016;11:31-9; discussion 39. 
10.  El Sabbagh A, Eleid MF, Al-Hijji M, Anavekar NS, 
Holmes DR, Nkomo VT, Oderich GS, Cassivi SD, Said 
SM, Rihal CS, Matsumoto JM, Foley TA. The Various 
Applications of 3D Printing in Cardiovascular Diseases. 
Curr Cardiol Rep 2018;20:47. 
11.  Aldosari S, Squelch A, Sun Z. Patient-specific three-
dimensional printed pulmonary artery model: A 
preliminary study. Digit Med 2017;3:170-7. 
12.  Kurzyna M, Araszkiewicz A, Błaszczak P, Grabka M, 
Hawranek M, Kopeć G, Mroczek E, Zembala M, 
Torbicki A, Ochała A. Summary of recommendations 
for the haemodynamic and angiographic assessment 
29Quantitative Imaging in Medicine and Surgery, Vol 9, No 1 January 2019
© Quantitative Imaging in Medicine and Surgery. All rights reserved.   Quant Imaging Med Surg 2019;9(1):23-29qims.amegroups.com
of the pulmonary circulation. Joint statement of the 
Polish Cardiac Society’s Working Group on Pulmonary 
Circulation and Association of Cardiovascular 
Interventions. Kardiol Pol 2015;73:63-8. 
13.  Fedorov A, Beichel R, Kalphaty-Cramer J, Finet J, Fillion-
Robbin JC, Pujol S, Bauer C, Jennings D, Fennessy F, 
Sonka M, Buatti J, Aylward S, Miller JV, Pieper S, Kikinis 
R. 3D Slicer as an Image Computing Platform for the 
Quantitative Imaging Network. Magn Reson Imaging 
2012;30:1323-41. 
14.  Witowski JS, Pędziwiatr M, Major P, Budzyński A. 
Cost-effective, personalized, 3D-printed liver model 
for preoperative planning before laparoscopic liver 
hemihepatectomy for colorectal cancer metastases. Int J 
Comput Assist Radiol Surg 2017;12:2047-54. 
15.  Lodziński P, Balsam P, Peller M, Kamiński J, Opolski 
G. First-in-man percutaneous pulmonary vein isolation 
enhanced by augmented reality system. Kardiol Pol 
2018;76:475. 
Cite this article as: Witowski J, Darocha S, Kownacki Ł, 
Pietrasik A, Pietura R, Banaszkiewicz M, Kamiński J, Biederman 
A, Torbicki A, Kurzyna M. Augmented reality and 3D 
printing in percutaneous interventions on pulmonary arteries. 
Quant Imaging Med Surg 2019;9(1):23-29. doi: 10.21037/
qims.2018.09.08
